Biocon Ltd (BIOCON) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,89%	1 083,04	−9,76	−0,89%	—	1 092,80	1 093,68	1 094,85	1 081,97	—	—
SIXC Communications SIXC Communications	SIXC −0,39%	602,38	−2,36	−0,39%	—	604,74	604,74	605,10	601,34	—	—
SIXE Energy SIXE Energy	SIXE +2,31%	1 242,83	+28,03	+2,31%	—	1 214,80	1 220,81	1 243,82	1 220,81	—	—
SIXI Industrials SIXI Industrials	SIXI −0,62%	1 713,82	−10,75	−0,62%	—	1 724,57	1 727,02	1 732,30	1 707,43	—	—
SIXM Financials SIXM Financials	SIXM +0,09%	639,99	+0,56	+0,09%	—	639,43	641,58	644,53	637,50	—	—
SIXR Staples SIXR Staples	SIXR −0,20%	837,46	−1,69	−0,20%	—	839,15	836,90	840,48	832,89	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,65%	214,22	−1,40	−0,65%	—	215,62	215,62	216,21	213,48	—	—
SIXT Technology SIXT Technology	SIXT +0,78%	3 204,38	+24,86	+0,78%	—	3 179,52	3 191,50	3 205,09	3 177,75	—	—
SIXU Utilities SIXU Utilities	SIXU −1,23%	925,38	−11,53	−1,23%	—	936,91	935,42	937,17	923,20	—	—
SIXV Health care SIXV Health care	SIXV −0,69%	1 442,71	−10,06	−0,69%	—	1 452,77	1 445,93	1 447,43	1 434,91	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,16%	2 361,34	−3,84	−0,16%	—	2 365,18	2 353,64	2 368,10	2 347,80	—	—

BIOCON:NSE

Biocon Ltd

358,65 INR

−0,99%

(−3,60) 1 D

30. apr., 15:30:01 GMT+5:30 · INR

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for BIOCON …

Åpne

360,50 INR

Høy

361,65 INR

Lav

354,25 INR

Markedsverdi

580,84 mrd.

Snittvolum

3,39 mill.

Volum

2,00 mill.

Utbytte

0,14 %

Kvartalsvis utbytte

0,13 INR

Første dato etter utbytte

4. juli 2025

P/E-forhold

73,95

52 u høy

424,95 INR

52 u lav

317,00 INR

EPS

4,85 INR

Utestående aksjer

600,00 mill.

Antall ansatte

16k

Relaterte aksjer

SUNPHARMA

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd

4 192,10 INR

−0,93%

SBICARD

SBI Cards and Payment Services Ltd

645,00 INR

−0,95%

Nyhetssaker

Fra kilder på nettet

CNBC

for 1 døgn siden

Can AI outperform doctors? Experts weigh the pros and cons

Profil

Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. The company was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA. Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia

Om Biocon Ltd

Administrerende direktørSiddharth Mittal

Ansatte16,4k

Grunnlagt29. nov. 1978

HovedkontorBangalore, Karnataka, India

Sektor-

Nettstedbiocon.com

Alle verdier i INR	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	44,17 mrd.	39,42 mrd.	42,96 mrd.	41,73 mrd.
Varekostnad	22,93 mrd.	14,05 mrd.	17,72 mrd.	13,39 mrd.
Direkte driftskostnader	22,93 mrd.	14,05 mrd.	17,72 mrd.	13,39 mrd.
Utgifter til forskning og utvikling	−370,00 mill.	−346,00 mill.	−132,00 mill.	−531,00 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	11,62 mrd.	8,33 mrd.	9,59 mrd.	8,75 mrd.
Driftskostnader	14,18 mrd.	22,43 mrd.	21,18 mrd.	25,16 mrd.
Totale driftskostnader	37,11 mrd.	36,48 mrd.	38,90 mrd.	38,55 mrd.
Driftsinntekter	7,06 mrd.	2,94 mrd.	4,05 mrd.	3,18 mrd.
Andre ikke-operasjonelle inntekter	−1,23 mrd.	−11,62 mrd.	94,00 mill.	1,17 mrd.
EBT inkludert uvanlige elementer	4,87 mrd.	969,00 mill.	1,71 mrd.	−678,00 mill.
EBT uten uvanlige elementer	4,36 mrd.	−11,45 mrd.	1,23 mrd.	2,26 mrd.
Kostnad for inntektsskatt	274,00 mill.	77,00 mill.	385,00 mill.	−160,00 mill.
Faktisk avgiftssats	5,63 %	7,95 %	22,48 %	23,60 %
Andre driftskostnader	−1,46 mrd.	9,89 mrd.	6,72 mrd.	11,78 mrd.
Nettoinntekt	3,44 mrd.	314,00 mill.	845,00 mill.	1,44 mrd.
Netto fortjenestemargin	7,80 %	0,80 %	1,97 %	3,45 %
Resultat per aksje	2,71	0,26	0,72	2,74
Rente- og investeringsinntekter	1,12 mrd.	-	235,00 mill.	-
Rentekostnader	−2,03 mrd.	−2,77 mrd.	−2,72 mrd.	−2,10 mrd.
Netto rentekostnader	−912,00 mill.	−2,77 mrd.	−2,49 mrd.	−2,10 mrd.
Avskrivnings- og amortiseringskostnader	4,36 mrd.	4,55 mrd.	4,73 mrd.	5,15 mrd.
EBITDA	11,01 mrd.	6,89 mrd.	8,69 mrd.	7,13 mrd.
Gevinst eller tap ved salg av eiendeler	-	-	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning